Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Gross Margin (2018 - 2025)

Exagen (XGN) has disclosed Gross Margin for 8 consecutive years, with 55.35% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 673.0% year-over-year to 55.35%, compared with a TTM value of 58.28% through Dec 2025, down 123.0%, and an annual FY2025 reading of 58.28%, down 123.0% over the prior year.
  • Gross Margin was 55.35% for Q4 2025 at Exagen, down from 58.43% in the prior quarter.
  • Across five years, Gross Margin topped out at 62.08% in Q4 2024 and bottomed at 20.09% in Q2 2022.
  • Average Gross Margin over 5 years is 54.83%, with a median of 57.93% recorded in 2023.
  • The sharpest move saw Gross Margin plummeted -3723bps in 2022, then soared 3863bps in 2023.
  • Year by year, Gross Margin stood at 61.08% in 2021, then fell by -17bps to 50.85% in 2022, then grew by 16bps to 59.17% in 2023, then rose by 5bps to 62.08% in 2024, then dropped by -11bps to 55.35% in 2025.
  • Business Quant data shows Gross Margin for XGN at 55.35% in Q4 2025, 58.43% in Q3 2025, and 60.43% in Q2 2025.